Navigation Links
Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
Date:2/17/2012

SAN DIEGO, Feb. 17, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be hosting limited registration training classes for CDISC, a global, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data. The classes will be held Feb. 21-24, 2012 at Synteract's Carlsbad, Calif., headquarters.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

CDSIC collaborates with CROs, including Synteract, to develop uniform data standards for clinical trials. Synteract has provided feedback and industry expertise to CDISC during this process as well as assistance with creating uniform data sets that meet the needs of CROs.  Synteract, in turn, uses its knowledge of regulatory requirements and standards to guide clients.

The classes will cover CDSIC standards and are appropriate for data management and biostatistics professionals in biotech and pharma companies. The training will be conducted by CDISC teachers and a class list and registration are available on CDISC's website. Synteract will also be hosting classes for CDISC Aug. 21-24, 2012 at its North Carolina office.

"Synteract is pleased to support CDISC's mission to improve medical research through platform-independent data standards. Working with CDISC places Synteract at the forefront of industry standards, which we can then pass onto our clients to guide them in the drug development process and ensure data is collected accurately from the start," explained Stewart Bieler, chief operating officer at Synteract. 

Synteract is also assisting with CDASH, a volunteer initiative CDISC began to create a global library of standardized data sets. Synteract currently has three employees contributing to the CDASH project.

About Synteract, Inc. (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:

Rachel Hutman
Clearpoint Agency, for Synteract
Rachel@clearpointagency.com
760-230-2424

 

 

 


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
2. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
3. National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012
4. HITECH Act Puts Security of Electronic Medical Records in Hands of Hosting Providers
5. Manhattans Physicians Group Selects ITelagen for Hosting and Management of EHR
6. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
7. DATATRAK Receives CDISC Registered Solutions Provider Status
8. Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
9. MedNet Solutions ENLIGHTEN Receives CDISC ODM Certification
10. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
11. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/18/2017)... ALLENTOWN , Pa. and KALAMAZOO, Mich. ... Allentown, Penn. , and OptiMed Specialty Pharmacy ... a business partnership to offer a strategic hub service ... PMD Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, ... A spirometer is a medical device used ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):